Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
NCT07159061

Neurofeedback to Treat Depression - 2

Led by University of Pennsylvania · Updated on 2025-12-04

80

Participants Needed

1

Research Sites

158 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study tests the efficacy of a new psychotherapeutic strategy for reducing negative attention bias (and therefore depression severity) in participants with MDD. This real-time fMRI neurofeedback therapy uses cloud-based pattern classification to decode a patient's attentional state and dynamically modulate task stimuli (in a closed loop) based on this state.

CONDITIONS

Official Title

Neurofeedback to Treat Depression - 2

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Gender inclusive
  • Adult aged 18 to 65
  • Meets DSM-5 criteria for MDD according to the Clinician-Administered MDD Scale (unipolar depression or bipolar II depressed)
  • Minimum score of 16 on Montgomery Asberg Depression Rating Scale (MADRS)
  • Normal cognition
  • Able to read and understand English
  • Able to provide consent
Not Eligible

You will not qualify if you...

  • Pregnancy (female participants)
  • Outside age range
  • MRI contraindications (medical implant, claustrophobia, etc.)
  • Use of psychoactive medication or currently in therapy
  • Neurological disorder or conditions impacting brain data or causing depression
  • Co-morbid psychotic or neurological disorders
  • Developmental or cognitive disabilities or impairments
  • Active alcohol or drug abuse/dependence within past 6 months
  • Non-English speaking
  • Non-correctable vision loss
  • Refusal to provide informed consent
  • Active suicide risk

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Center for Neuromodulation in Depression and Stress

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

Loading map...

Research Team

Y

Yvette Sheline, M.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here